SIWA Biotech Corp.

OKLAHOMA CITY, OK · CIK 0001657894 · Biotech · Defunct

Precision fermentation platform using AI and microbiology to design and scale biological molecules for health, nutrition, and protein production

siwa.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$8.7M
3 Form D · Dec 2017
106 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$5,290,105
Private capital raisedForm D · SEC$1,999,998
Private capital raisedForm D · SEC$1,410,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1436TransChromix LLC——
1437ENTERX BIOSCIENCES, INC.——
1438UCB S.A.—$788K
1439SIWA Biotech Corp.—$8.7M
1440ARTBIO——
1441KJ BIOSCIENCES, LLC——
1442Centaurus Therapeutics, Inc.—$2.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Jerald BaldwinDirector
  • William CanfieldDirector · Executive Officer
  • J HeadDirector
  • Kevin MooreDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.